Mainstream

Icon signals $8B full-year revenue midpoint as metabolic and obesity trial momentum builds

Icon signals $8B full-year revenue midpoint as metabolic and obesity trial momentum builds

Post ContenticlrRead More

You might also be interested in reading Cathie Wood’s Ark Invest expects Tesla to soar to $3,000 per share by 2025 on robotaxi service.

July 24, 2025
In Mainstream